Evidence map›Paper›PMID 33350884›Full record

ArticleVascular medicine (London, England)2021

Expression of Interleukin 6 signaling receptors in carotid atherosclerosis.

Louise Ziegler, Jasmin Lundqvist, Kristian Dreij, Håkan Wallén, Ulf de Faire, Gabrielle Paulsson-Berne, Ulf Hedin, Ljubica Matic, Bruna Gigante

Open access · hybridAbstract read
In one paragraph

Article in Vascular medicine (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Louise ZieglerDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6109-6761
Jasmin LundqvistCardiovascular Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Kristian DreijUnit of Biochemical Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Håkan WallénDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Ulf de FaireUnit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Gabrielle Paulsson-BerneCardiovascular Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Ulf HedinDepartment of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden.
Ljubica MaticDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Bruna GiganteCardiovascular Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEDanderyds sjukhus · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin (IL) 6 contributes to atherosclerotic plaque development through IL6 membrane-bound (IL6R and gp130) and soluble (sIL6R and sgp130) receptors. We investigated IL6 receptor expression in carotid plaques and its correlation with circulating IL6 and soluble receptor levels. Plasma samples and carotid plaques were obtained from 78 patients in the Biobank of Karolinska Endarterectomies study. IL6, sIL6R, and sgp130 were measured in plasma and

Indexed as

Plaque, AtheroscleroticAgedBiomarkersCarotid ArteriesCarotid StenosisCross-Sectional StudiesCytokine Receptor gp130Endarterectomy, CarotidFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInterleukin-6MaleReceptors, Interleukin-6Signal TransductionBiomarkersCytokine Receptor gp130Hydroxymethylglutaryl-CoA Reductase InhibitorsIL6 protein, humanIL6R protein, humanIL6ST protein, humanInterleukin-6Receptors, Interleukin-6atherosclerosiscarotid artery diseasecerebrovascular diseaseinflammationinterleukin 6 (IL6)

Identifiers

PMID33350884
PMCPMC7879223
OpenAlexW3117189248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.